
Sarcoidosis is a systemic granulomatous disease predominantly affecting the lungs. The mechanisms promoting disease pathogenesis and progression are unknown, although interleukin-15 (IL-15) has been associated with the immune-mediated inflammation of sarcoidosis. Because the identification of a mechanistically-based, clinically-relevant biomarker for sarcoidosis remains elusive, we hypothesized this role for IL-15...
Like
Save
Share